These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 22986536
1. Notch1 signaling contributes to the oncogenic effect of HBx on human hepatic cells. Wang F, Xia X, Wang J, Sun Q, Luo J, Cheng B. Biotechnol Lett; 2013 Jan; 35(1):29-37. PubMed ID: 22986536 [Abstract] [Full Text] [Related]
2. Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein-associated hepatocellular carcinoma. Sun Q, Wang R, Wang Y, Luo J, Wang P, Cheng B. Oncol Rep; 2014 Feb; 31(2):933-9. PubMed ID: 24336972 [Abstract] [Full Text] [Related]
3. The hepatitis B virus X protein downregulates NF-κB signaling pathways through decreasing the Notch signaling pathway in HBx-transformed L02 cells. Luo J, Zhou H, Wang F, Xia X, Sun Q, Wang R, Cheng B. Int J Oncol; 2013 May; 42(5):1636-43. PubMed ID: 23450368 [Abstract] [Full Text] [Related]
4. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Qi R, An H, Yu Y, Zhang M, Liu S, Xu H, Guo Z, Cheng T, Cao X. Cancer Res; 2003 Dec 01; 63(23):8323-9. PubMed ID: 14678992 [Abstract] [Full Text] [Related]
5. Hepatitis B virus X protein blunts senescence-like growth arrest of human hepatocellular carcinoma by reducing Notch1 cleavage. Xu J, Yun X, Jiang J, Wei Y, Wu Y, Zhang W, Liu Y, Wang W, Wen Y, Gu J. Hepatology; 2010 Jul 01; 52(1):142-54. PubMed ID: 20578140 [Abstract] [Full Text] [Related]
9. Activated Notch signaling is required for hepatitis B virus X protein to promote proliferation and survival of human hepatic cells. Wang F, Zhou H, Xia X, Sun Q, Wang Y, Cheng B. Cancer Lett; 2010 Dec 01; 298(1):64-73. PubMed ID: 20638778 [Abstract] [Full Text] [Related]
11. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes]. Fu XY, Tan DM, Hou ZH, Hu ZL, Liu GZ, Ouyang Y, Liu F. Zhonghua Gan Zang Bing Za Zhi; 2012 Aug 01; 20(8):598-604. PubMed ID: 23207154 [Abstract] [Full Text] [Related]
12. Hepatitis B virus X protein promotes interleukin-7 receptor expression via NF-κB and Notch1 pathway to facilitate proliferation and migration of hepatitis B virus-related hepatoma cells. Kong F, Hu W, Zhou K, Wei X, Kou Y, You H, Zheng K, Tang R. J Exp Clin Cancer Res; 2016 Nov 07; 35(1):172. PubMed ID: 27821177 [Abstract] [Full Text] [Related]
13. Hepatitis B virus X protein activates CD59 involving DNA binding and let-7i in protection of hepatoma and hepatic cells from complement attack. Shan C, Zhang S, Cui W, You X, Kong G, Du Y, Qiu L, Ye L, Zhang X. Carcinogenesis; 2011 Aug 07; 32(8):1190-7. PubMed ID: 21665888 [Abstract] [Full Text] [Related]
14. Notch1 activation contributes to tumor cell growth and proliferation in human hepatocellular carcinoma HepG2 and SMMC7721 cells. Gao J, Dong Y, Zhang B, Xiong Y, Xu W, Cheng Y, Dai M, Yu Z, Xu H, Zheng G. Int J Oncol; 2012 Nov 07; 41(5):1773-81. PubMed ID: 22922832 [Abstract] [Full Text] [Related]
16. Knock-down of hepatitis B virus X protein reduces the tumorigenicity of hepatocellular carcinoma cells. Chan DW, Ng IO. J Pathol; 2006 Feb 07; 208(3):372-80. PubMed ID: 16353167 [Abstract] [Full Text] [Related]
17. Regulation of ERK and AKT pathways by hepatitis B virus X protein via the Notch1 pathway in hepatocellular carcinoma. Liao B, Zhou H, Liang H, Li C. Int J Oncol; 2017 Nov 07; 51(5):1449-1459. PubMed ID: 29048612 [Abstract] [Full Text] [Related]
18. [Hepatitis B virus X promotes HepG2 cell cycle progression and growth via downregulation expression of p16 protein]. Mai L, Yang L, Kuang JY, Zhu JY, Kang YH, Zhang FC, Xie QF, Gao ZL. Zhonghua Gan Zang Bing Za Zhi; 2013 Aug 07; 21(8):614-8. PubMed ID: 24119743 [Abstract] [Full Text] [Related]
19. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line. Mazzanti R, Platini F, Bottini C, Fantappiè O, Solazzo M, Tessitore L. Biochem Pharmacol; 2009 Jul 01; 78(1):21-32. PubMed ID: 19447220 [Abstract] [Full Text] [Related]
20. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells. Urbanik T, Köhler BC, Boger RJ, Wörns MA, Heeger S, Otto G, Hövelmeyer N, Galle PR, Schuchmann M, Waisman A, Schulze-Bergkamen H. Int J Oncol; 2011 Jan 01; 38(1):121-31. PubMed ID: 21109933 [Abstract] [Full Text] [Related] Page: [Next] [New Search]